CN111840172A - 一种美肤紧致乳霜及其制备方法 - Google Patents
一种美肤紧致乳霜及其制备方法 Download PDFInfo
- Publication number
- CN111840172A CN111840172A CN202010876791.XA CN202010876791A CN111840172A CN 111840172 A CN111840172 A CN 111840172A CN 202010876791 A CN202010876791 A CN 202010876791A CN 111840172 A CN111840172 A CN 111840172A
- Authority
- CN
- China
- Prior art keywords
- phase
- extract
- following components
- cream
- filtering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006071 cream Substances 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 21
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 21
- 241000157280 Aesculus hippocastanum Species 0.000 claims abstract description 19
- 235000010181 horse chestnut Nutrition 0.000 claims abstract description 19
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims abstract description 14
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 241000208681 Hamamelis virginiana Species 0.000 claims abstract description 13
- 240000004385 Centaurea cyanus Species 0.000 claims abstract description 10
- 235000005940 Centaurea cyanus Nutrition 0.000 claims abstract description 10
- 241000195480 Fucus Species 0.000 claims abstract description 10
- -1 jojoba oil Chemical compound 0.000 claims abstract description 8
- AJLNZWYOJAWBCR-OOPVGHQCSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O AJLNZWYOJAWBCR-OOPVGHQCSA-N 0.000 claims abstract description 7
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 claims abstract description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000004475 Arginine Substances 0.000 claims abstract description 7
- 102000014171 Milk Proteins Human genes 0.000 claims abstract description 7
- 108010011756 Milk Proteins Proteins 0.000 claims abstract description 7
- 229920001214 Polysorbate 60 Polymers 0.000 claims abstract description 7
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 7
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 7
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims abstract description 7
- 241001135917 Vitellaria paradoxa Species 0.000 claims abstract description 7
- 229940095094 acetyl hexapeptide-8 Drugs 0.000 claims abstract description 7
- 108010006338 acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide Proteins 0.000 claims abstract description 7
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229960001631 carbomer Drugs 0.000 claims abstract description 7
- 229940082500 cetostearyl alcohol Drugs 0.000 claims abstract description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229940087068 glyceryl caprylate Drugs 0.000 claims abstract description 7
- 229940100554 isononyl isononanoate Drugs 0.000 claims abstract description 7
- 229940119170 jojoba wax Drugs 0.000 claims abstract description 7
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims abstract description 7
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims abstract description 7
- 229960002216 methylparaben Drugs 0.000 claims abstract description 7
- 235000021239 milk protein Nutrition 0.000 claims abstract description 7
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims abstract description 7
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 claims abstract description 7
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 claims abstract description 7
- 229940113124 polysorbate 60 Drugs 0.000 claims abstract description 7
- 229960004063 propylene glycol Drugs 0.000 claims abstract description 7
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229940057910 shea butter Drugs 0.000 claims abstract description 7
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 7
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 7
- 229940032094 squalane Drugs 0.000 claims abstract description 7
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000011732 tocopherol Substances 0.000 claims abstract description 7
- 229960001295 tocopherol Drugs 0.000 claims abstract description 7
- 229930003799 tocopherol Natural products 0.000 claims abstract description 7
- 235000010384 tocopherol Nutrition 0.000 claims abstract description 7
- 239000000230 xanthan gum Substances 0.000 claims abstract description 7
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 7
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 7
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 7
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims abstract description 7
- 239000002253 acid Substances 0.000 claims abstract description 4
- 229960005150 glycerol Drugs 0.000 claims abstract description 4
- 240000004246 Agave americana Species 0.000 claims abstract 4
- 238000001914 filtration Methods 0.000 claims description 30
- 238000003756 stirring Methods 0.000 claims description 30
- 239000000243 solution Substances 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 241000723353 Chrysanthemum Species 0.000 claims description 12
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
- 239000000047 product Substances 0.000 claims description 10
- 230000001476 alcoholic effect Effects 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 238000001816 cooling Methods 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- 238000004090 dissolution Methods 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000003480 eluent Substances 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000003208 petroleum Substances 0.000 claims description 6
- 239000002244 precipitate Substances 0.000 claims description 6
- 241000227647 Fucus vesiculosus Species 0.000 claims description 3
- 241000208680 Hamamelis mollis Species 0.000 claims description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 3
- 240000009132 Sagittaria sagittifolia Species 0.000 claims description 3
- 235000006466 Sagittaria sagittifolia Nutrition 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims description 3
- 239000004327 boric acid Substances 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 238000005520 cutting process Methods 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 230000001804 emulsifying effect Effects 0.000 claims description 3
- 238000000855 fermentation Methods 0.000 claims description 3
- 230000004151 fermentation Effects 0.000 claims description 3
- 235000020721 horse chestnut extract Nutrition 0.000 claims description 3
- RGUVUPQQFXCJFC-UHFFFAOYSA-N n-hydroxyoctanamide Chemical compound CCCCCCCC(=O)NO RGUVUPQQFXCJFC-UHFFFAOYSA-N 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 239000011347 resin Substances 0.000 claims description 3
- 229920005989 resin Polymers 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 238000001179 sorption measurement Methods 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 229940118846 witch hazel Drugs 0.000 claims description 3
- 206010030113 Oedema Diseases 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 16
- 244000193174 agave Species 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 238000005536 corrosion prevention Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229940011399 escin Drugs 0.000 description 1
- 229930186222 escin Natural products 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种美肤紧致乳霜，属于护肤品技术领域，所述按摩霜包含A相、B相、C相、D相、E相和F相；所述A相包含如下组分：甘油、丙二醇、黄原胶、卡波姆、羟苯甲酯、水；所述B相包含如下组分：角鲨烷、霍霍巴籽油、异壬酸异壬酯、牛油果树果脂、鲸蜡硬脂醇、聚山梨醇酯‑60、生育酚；所述C相包含如下组分：牛奶蛋白、水解燕麦蛋白、透明质酸钠、龙舌兰叶提取物、北美金缕梅提取物、墨角藻提取物、矢车菊花提取物、欧洲七叶树提取物、乙酰基六肽‑8、咖啡提取物；所述D相包含如下组分：精氨酸；所述E相包含如下组分：辛酰羟肟酸、甘油辛酸酯；所述F相包含如下组分：CI 16255。本美肤紧致乳霜能去除水肿，改善肤色，使肌肤光滑润泽有弹性。
Description
技术领域
本发明属于护肤品技术领域，具体涉及一种美肤紧致乳霜及其制备方法。
背景技术
随着社会经济的不断进步和人们物质生活的日益丰富，各种美容护肤品的需求量也随之不断增长。而目前市场上的护肤品种类繁多，性能各异，功效取向均较单一，难以满足大多数人希望的单品多功效的需求。并且由于各种天然成分的混合、防腐、防氧化等诸多难题难以克服，以及为了降低生产成本等因素，至今市场上绝大部分的国内外产品仍然采用化工时代的底料，添加了一些天然成分即为“天然化妆品”，大多只是噱头而己！也是现今美容护肤品业界的一个普遍现象。
乳霜是现在人们生活中常用的护肤品，目前市场上很难见到有效改善皮肤品质，又具有安全环保性的产品。
发明内容
本发明的目的是提供一种美肤紧致乳霜及其制备方法。
本发明的上述技术目的是通过以下技术方案实现的：
一种美肤紧致乳霜，所述按摩霜包含A相、B相、C相、D相、E相和F相；
所述A相包含如下组分：甘油、丙二醇、黄原胶、卡波姆、羟苯甲酯、水；
所述B相包含如下组分：角鲨烷、霍霍巴籽油、异壬酸异壬酯、牛油果树果脂、鲸蜡硬脂醇、聚山梨醇酯-60、生育酚；
所述C相包含如下组分：牛奶蛋白、水解燕麦蛋白、透明质酸钠、龙舌兰叶提取物、北美金缕梅提取物、墨角藻提取物、矢车菊花提取物、欧洲七叶树提取物、乙酰基六肽-8、咖啡提取物；
所述D相包含如下组分：精氨酸；
所述E相包含如下组分：辛酰羟肟酸、甘油辛酸酯；
所述F相包含如下组分：CI 16255。
进一步的，所述按摩霜包含A相、B相、C相、D相、E相和F相；
所述A相中各组分在乳霜中所占的重量百分比为：2％甘油、2％丙二醇、0.1％黄原胶、0.1％卡波姆、0.1％羟苯甲酯、余量为水；
所述B相中各组分在乳霜中所占的重量百分比为：2％角鲨烷、2％霍霍巴籽油、2％异壬酸异壬酯、2％牛油果树果脂、1％鲸蜡硬脂醇、1％聚山梨醇酯-60、0.5％生育酚；
所述C相中各组分在乳霜中所占的重量百分比为：0.5％牛奶蛋白、0.5％水解燕麦蛋白、0.1％透明质酸钠、2％龙舌兰叶提取物、2％北美金缕梅提取物、2％墨角藻提取物、2％矢车菊花提取物、2％欧洲七叶树提取物、0.1％乙酰基六肽-8、0.1％咖啡提取物；
所述D相中各组分在乳霜中所占的重量百分比为：0.1％精氨酸；
所述E相中各组分在乳霜中所占的重量百分比为：0.2％辛酰羟肟酸、0.2％甘油辛酸酯；
所述F相中各组分在乳霜中所占的重量百分比为：0.001％CI16255。
进一步的，所述龙舌兰叶提取物的制备方法包括如下步骤：取龙蛇兰叶洗净切碎，加入乙醇溶解，恒温水浴回流2h,过滤浓缩至无醇味，将浓缩液用石油醚脱脂，弃去上层石油醚层，脱脂后的溶液用水饱和正丁醇萃取4次，合并萃取液，过滤而得；它可以有效抑制透明质酸的分解，因而具有皮肤保湿的作用；增加皮肤角质层的含水量，具有保湿抗皱功效。
所述北美金缕梅提取物的制备方法包括如下步骤：取北美金缕梅粉碎，加入水中，加入硼酸在60-70℃提取1-2h，过滤，取上清液，加入柠檬酸调节pH至3.5-3.8，室温提取20-24h，然后加入盐酸调节pH至3.5-3.8，加热至75-85℃，保温30-35min，过滤，得到沉淀物，向沉淀物中加入体积分数为65-70％的乙醇溶液，在70-75℃下提取1.5-1.8h，过滤，得到滤渣和上清液，取上清液，浓缩，干燥，制得北美金缕梅提取物；它是一种很强的抗氧化剂及收敛剂，能很好的保养皮肤。
所述墨角藻提取物的制备方法包括如下步骤：取墨角藻粉末,加入溶剂,搅拌,过滤得到滤渣；再向所述滤渣中加入水,搅拌提取过，滤得到滤液,冷却至室温；将所述滤液加入装有大孔吸附树脂层析柱内,先用水溶液洗脱,再用醇溶液洗脱,并收集醇溶液洗脱液,然后将醇溶液洗脱液浓缩、干燥即可；它可以加速伤口的愈合，润泽肌肤，延缓肌肤的衰老，使皮肤细滑光洁。
所述矢车菊花提取物的制备方法包括如下步骤：取矢菊花加水煎煮1-2h，滤取菊花液，菊花渣再加水煎煮0.5-1h，滤取菊花液，弃菊花渣，合并两次煎液，将煎液浓缩至60℃以下密度1.05-1.2，冷却至常温后即可；具有消炎抗菌，舒缓皮肤，使皮肤具有弹性。
所述欧洲七叶树提取物的制备方法包括如下步骤：将欧洲七叶树籽进行清洗，以50-55：35-50的质量比加入去离子水，粗粉碎，得到混合的欧洲七叶树籽初浆；将所得的欧洲七叶树籽发酵物进行搅拌离心过滤，除去滤渣，得到欧洲七叶树提取物。该成分的消肿效果好，七叶皂素中含有对抗自由基，对抗氧化的功效，经常使用可以有效抗衰老，改善肌肤的微循环。
一种美肤紧致乳霜的制备方法，包括如下步骤：
1)将A相投入乳化锅，升温至85℃，均质并搅拌，确保溶解均匀，保温搅拌30min后备用；
2)将B相升温至80℃，溶解完全，确保溶解均匀，保温搅拌30min后备用；
3)80℃条件下将A、B两相均质并搅拌均匀，搅拌20min；
4)降温至45℃，再加入C相，搅拌均匀；
5)45℃条件下加入D相、E相、F相搅拌均匀后即可。
本发明相比现有技术具有以下优点：
本发明美肤紧致乳霜能有效的去除水肿，并能紧致肌肤，改善肤色，使肌肤光滑润泽，增加肌肤弹性，很好的保持了肌肤的水分，同时具有安全环保的使用特性，极具推广应用价值。
具体实施方式
一种美肤紧致乳霜，所述按摩霜包含A相、B相、C相、D相、E相和F相；
所述A相包含如下组分：甘油、丙二醇、黄原胶、卡波姆、羟苯甲酯、水；
所述B相包含如下组分：角鲨烷、霍霍巴籽油、异壬酸异壬酯、牛油果树果脂、鲸蜡硬脂醇、聚山梨醇酯-60、生育酚；
所述C相包含如下组分：牛奶蛋白、水解燕麦蛋白、透明质酸钠、龙舌兰叶提取物、北美金缕梅提取物、墨角藻提取物、矢车菊花提取物、欧洲七叶树提取物、乙酰基六肽-8、咖啡提取物；
所述D相包含如下组分：精氨酸；
所述E相包含如下组分：辛酰羟肟酸、甘油辛酸酯；
所述F相包含如下组分：CI 16255。
所述按摩霜包含A相、B相、C相、D相、E相和F相；
所述A相中各组分在乳霜中所占的重量百分比为：2％甘油、2％丙二醇、0.1％黄原胶、0.1％卡波姆、0.1％羟苯甲酯、余量为水；
所述B相中各组分在乳霜中所占的重量百分比为：2％角鲨烷、2％霍霍巴籽油、2％异壬酸异壬酯、2％牛油果树果脂、1％鲸蜡硬脂醇、1％聚山梨醇酯-60、0.5％生育酚；
所述C相中各组分在乳霜中所占的重量百分比为：0.5％牛奶蛋白、0.5％水解燕麦蛋白、0.1％透明质酸钠、2％龙舌兰叶提取物、2％北美金缕梅提取物、2％墨角藻提取物、2％矢车菊花提取物、2％欧洲七叶树提取物、0.1％乙酰基六肽-8、0.1％咖啡提取物；
所述D相中各组分在乳霜中所占的重量百分比为：0.1％精氨酸；
所述E相中各组分在乳霜中所占的重量百分比为：0.2％辛酰羟肟酸、0.2％甘油辛酸酯；
所述F相中各组分在乳霜中所占的重量百分比为：0.001％CI16255。
所述龙舌兰叶提取物的制备方法包括如下步骤：取龙蛇兰叶洗净切碎，加入乙醇溶解，恒温水浴回流2h,过滤浓缩至无醇味，将浓缩液用石油醚脱脂，弃去上层石油醚层，脱脂后的溶液用水饱和正丁醇萃取4次，合并萃取液，过滤而得；
所述北美金缕梅提取物的制备方法包括如下步骤：取北美金缕梅粉碎，加入水中，加入硼酸在60-70℃提取1-2h，过滤，取上清液，加入柠檬酸调节pH至3.5-3.8，室温提取20-24h，然后加入盐酸调节pH至3.5-3.8，加热至75-85℃，保温30-35min，过滤，得到沉淀物，向沉淀物中加入体积分数为65-70％的乙醇溶液，在70-75℃下提取1.5-1.8h，过滤，得到滤渣和上清液，取上清液，浓缩，干燥，制得北美金缕梅提取物；
所述墨角藻提取物的制备方法包括如下步骤：取墨角藻粉末,加入溶剂,搅拌,过滤得到滤渣；再向所述滤渣中加入水,搅拌提取,过滤得到滤液,冷却至室温；将所述滤液加入装有大孔吸附树脂层析柱内,先用水溶液洗脱,再用醇溶液洗脱,并收集醇溶液洗脱液,然后将醇溶液洗脱液浓缩、干燥即可；
所述矢车菊花提取物的制备方法包括如下步骤：取矢菊花加水煎煮1-2h，滤取菊花液，菊花渣再加水煎煮0.5-1h，滤取菊花液，弃菊花渣，合并两次煎液，将煎液浓缩至60℃以下密度1.05-1.2，冷却至常温后即可；
所述欧洲七叶树提取物的制备方法包括如下步骤：将欧洲七叶树籽进行清洗，以50-55：35-50的质量比加入去离子水，粗粉碎，得到混合的欧洲七叶树籽初浆；将所得的欧洲七叶树籽发酵物进行搅拌离心过滤，除去滤渣，得到欧洲七叶树提取物。
一种美肤紧致乳霜的制备方法，包括如下步骤：
1)将A相投入乳化锅，升温至85℃，均质并搅拌，确保溶解均匀，保温搅拌30min后备用；
2)将B相升温至80℃，溶解完全，确保溶解均匀，保温搅拌30min后备用；
3)80℃条件下将A、B两相均质并搅拌均匀，搅拌20min；
4)降温至45℃，再加入C相，搅拌均匀；
5)45℃条件下加入D相、E相、F相搅拌均匀后即可。
Claims (4)
1.一种美肤紧致乳霜，其特征在于，所述按摩霜包含A相、B相、C相、D相、E相和F相；
所述A相包含如下组分：甘油、丙二醇、黄原胶、卡波姆、羟苯甲酯、水；
所述B相包含如下组分：角鲨烷、霍霍巴籽油、异壬酸异壬酯、牛油果树果脂、鲸蜡硬脂醇、聚山梨醇酯-60、生育酚；
所述C相包含如下组分：牛奶蛋白、水解燕麦蛋白、透明质酸钠、龙舌兰叶提取物、北美金缕梅提取物、墨角藻提取物、矢车菊花提取物、欧洲七叶树提取物、乙酰基六肽-8、咖啡提取物；
所述D相包含如下组分：精氨酸；
所述E相包含如下组分：辛酰羟肟酸、甘油辛酸酯；
所述F相包含如下组分：CI 16255。
2.根据权利要求1所述的一种美肤紧致乳霜，其特征在于，所述按摩霜包含A相、B相、C相、D相、E相和F相；
所述A相中各组分在乳霜中所占的重量百分比为：2％甘油、2％丙二醇、0.1％黄原胶、0.1％卡波姆、0.1％羟苯甲酯、余量为水；所述B相中各组分在乳霜中所占的重量百分比为：2％角鲨烷、2％霍霍巴籽油、2％异壬酸异壬酯、2％牛油果树果脂、1％鲸蜡硬脂醇、1％聚山梨醇酯-60、0.5％生育酚；
所述C相中各组分在乳霜中所占的重量百分比为：0.5％牛奶蛋白、0.5％水解燕麦蛋白、0.1％透明质酸钠、2％龙舌兰叶提取物、2％北美金缕梅提取物、2％墨角藻提取物、2％矢车菊花提取物、2％欧洲七叶树提取物、0.1％乙酰基六肽-8、0.1％咖啡提取物；
所述D相中各组分在乳霜中所占的重量百分比为：0.1％精氨酸；所述E相中各组分在乳霜中所占的重量百分比为：0.2％辛酰羟肟酸、0.2％甘油辛酸酯；
所述F相中各组分在乳霜中所占的重量百分比为：0.001％CI16255。
3.根据权利要求2所述的一种美肤紧致乳霜，其特征在于，所述龙舌兰叶提取物的制备方法包括如下步骤：取龙蛇兰叶洗净切碎，加入乙醇溶解，恒温水浴回流2h,过滤浓缩至无醇味，将浓缩液用石油醚脱脂，弃去上层石油醚层，脱脂后的溶液用水饱和正丁醇萃取4次，合并萃取液，过滤而得；
所述北美金缕梅提取物的制备方法包括如下步骤：取北美金缕梅粉碎，加入水中，加入硼酸在60-70℃提取1-2h，过滤，取上清液，加入柠檬酸调节pH至3.5-3.8，室温提取20-24h，然后加入盐酸调节pH至3.5-3.8，加热至75-85℃，保温30-35min，过滤，得到沉淀物，向沉淀物中加入体积分数为65-70％的乙醇溶液，在70-75℃下提取1.5-1.8h，过滤，得到滤渣和上清液，取上清液，浓缩，干燥，制得北美金缕梅提取物；
所述墨角藻提取物的制备方法包括如下步骤：取墨角藻粉末,加入溶剂,搅拌,过滤得到滤渣；再向所述滤渣中加入水,搅拌提取,过滤得到滤液,冷却至室温；将所述滤液加入装有大孔吸附树脂层析柱内,先用水溶液洗脱,再用醇溶液洗脱,并收集醇溶液洗脱液,然后将醇溶液洗脱液浓缩、干燥即可；
所述矢车菊花提取物的制备方法包括如下步骤：取矢菊花加水煎煮1-2h，滤取菊花液，菊花渣再加水煎煮0.5-1h，滤取菊花液，弃菊花渣，合并两次煎液，将煎液浓缩至60℃以下密度1.05-1.2，冷却至常温后即可；
所述欧洲七叶树提取物的制备方法包括如下步骤：将欧洲七叶树籽进行清洗，以50-55：35-50的质量比加入去离子水，粗粉碎，得到混合的欧洲七叶树籽初浆；将所得的欧洲七叶树籽发酵物进行搅拌离心过滤，除去滤渣，得到欧洲七叶树提取物。
4.一种美肤紧致乳霜的制备方法，其特征在于，包括如下步骤：
1)将A相投入乳化锅，升温至85℃，均质并搅拌，确保溶解均匀，保温搅拌30min后备用；
2)将B相升温至80℃，溶解完全，确保溶解均匀，保温搅拌30min后备用；
3)80℃条件下将A、B两相均质并搅拌均匀，搅拌20min；
4)降温至45℃，再加入C相，搅拌均匀；
5)45℃条件下加入D相、E相、F相搅拌均匀后即可。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010876791.XA CN111840172A (zh) | 2020-08-27 | 2020-08-27 | 一种美肤紧致乳霜及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010876791.XA CN111840172A (zh) | 2020-08-27 | 2020-08-27 | 一种美肤紧致乳霜及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111840172A true CN111840172A (zh) | 2020-10-30 |
Family
ID=72968339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010876791.XA Pending CN111840172A (zh) | 2020-08-27 | 2020-08-27 | 一种美肤紧致乳霜及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111840172A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112972340A (zh) * | 2021-04-12 | 2021-06-18 | 东晟源研究院(广州)有限公司 | 牛奶咖啡组合面膜配方及其制备方法 |
| CN112972288A (zh) * | 2021-03-31 | 2021-06-18 | 烟台泊奥俪泉商贸有限公司 | 抗衰老胶原蛋白护肤霜及其制备方法 |
| CN113069382A (zh) * | 2021-04-19 | 2021-07-06 | 李树玲 | 一种活肤霜 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103816072A (zh) * | 2014-01-24 | 2014-05-28 | 娇时化妆品（杭州）有限公司 | 一种植物精粹窈窕纤体霜 |
-
2020
- 2020-08-27 CN CN202010876791.XA patent/CN111840172A/zh active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103816072A (zh) * | 2014-01-24 | 2014-05-28 | 娇时化妆品（杭州）有限公司 | 一种植物精粹窈窕纤体霜 |
Non-Patent Citations (1)
| Title |
|---|
| MADELINEONLINE: "Etbella Morita Moisture Eye Sheets", 《HTTP://WWW.COSDNA.COM/CHS/COSMETIC_D5CD424622.HTML》, 2 March 2019 (2019-03-02), pages 1 - 6 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112972288A (zh) * | 2021-03-31 | 2021-06-18 | 烟台泊奥俪泉商贸有限公司 | 抗衰老胶原蛋白护肤霜及其制备方法 |
| CN112972340A (zh) * | 2021-04-12 | 2021-06-18 | 东晟源研究院(广州)有限公司 | 牛奶咖啡组合面膜配方及其制备方法 |
| CN113069382A (zh) * | 2021-04-19 | 2021-07-06 | 李树玲 | 一种活肤霜 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101547920B1 (ko) | 두피와 모발의 보호를 위한 천연 샴푸바 및 그 제조방법 | |
| CN103520036B (zh) | 一种防脱发洗发水 | |
| CN101873847A (zh) | 含有草药提取物复合物的皮肤外用组合物 | |
| CN111840172A (zh) | 一种美肤紧致乳霜及其制备方法 | |
| KR20150017087A (ko) | 마누카 꿀을 포함하는 비듬 및 두피가려움증 예방 및 개선용 모발 화장료 조성물 | |
| CN102639099A (zh) | 防脱发和改善头皮的发用化妆品组合物 | |
| CN101869541B (zh) | 一种含有植物提取物的护肤品及其制备方法 | |
| CN109106659A (zh) | 一种含有中草药提取物的护肤霜及制备方法 | |
| KR102166300B1 (ko) | 다기능성 미용비누 조성물 및 그 조성물을 이용한 다기능성 미용비누의 제조방법 | |
| CN105853280A (zh) | 一种金盏花爽肤水 | |
| CN106798656B (zh) | 一种包含牦牛骨小分子肽的深度养发素及其制备方法 | |
| CN108451818A (zh) | 一种榆树皮提取液及其制备方法和应用 | |
| CN111329801A (zh) | 一种保温护肤霜及其制备方法 | |
| CN107260641A (zh) | 一种男士醒肤露及其制备方法 | |
| KR20110030812A (ko) | 민감성 피부 및 두피용 화장료 조성물 | |
| CN101693002B (zh) | 芦荟提取液的生产工艺 | |
| KR100979143B1 (ko) | 생약추출물을 유효성분으로 함유하는 피부보습 및탄력개선용 화장료 조성물 | |
| CN107375087A (zh) | 一种沐浴露及其制备方法 | |
| KR20250054648A (ko) | 두피 케어 및 모발 상태 개선용 샴푸 조성물 | |
| KR101189794B1 (ko) | 양마 추출물을 함유하는 피부 외용제 조성물 | |
| CN111973472A (zh) | 一种神经酰胺赋活水及其制备方法 | |
| CN105147539A (zh) | 一种孕妇专用手足霜 | |
| KR20150105721A (ko) | 구기자나무의 복합추출물을 유효성분으로 함유하는 피부 노화 억제 화장료 조성물 | |
| CN103284901A (zh) | 红花润肤保健液制备方法 | |
| CN104666170A (zh) | 一种以泽泻白及银杏叶为主要功效成分的护肤品及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20201030 |